Paul Tudor Jones’s MacroGenics MGNX Stock Holding History

Paul Tudor Jones’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.5K	Sell	16,349 -80	-0.5%	-$303	﹤0.01%	3421
2026 Q1	$47.5K	Hold	16,429	–	–	﹤0.01%	3490
2025 Q4	$26.5K	Hold	16,429	–	–	﹤0.01%	3411
2025 Q3	$27.6K	Hold	16,429	–	–	﹤0.01%	3284
2025 Q2	$19.9K	Hold	16,429	–	–	﹤0.01%	3172
2025 Q1	$20.9K	Buy	16,429 +5,479	+50%	+$14.3K	﹤0.01%	2968
2024 Q4	$35.6K	Sell	10,950 -20,243	-65%	-$72.9K	﹤0.01%	2936
2024 Q3	$103K	Buy	+31,193	New	+$122K	﹤0.01%	2593
2023 Q4	–	Sell	-139,080	Closed	-$648K	–	2678
2023 Q3	$648K	Buy	139,080 +384	+0.3%	+$1.91K	0.01%	1545
2023 Q2	$742K	Buy	138,696 +80,760	+139%	+$498K	0.01%	1491
2023 Q1	$415K	Buy	57,936 +26,781	+86%	+$161K	0.01%	1725
2022 Q4	$209K	Sell	31,155 -89,468	-74%	-$491K	﹤0.01%	2119
2022 Q3	$417K	Sell	120,623 -33,708	-22%	-$129K	0.01%	1528
2022 Q2	$455K	Buy	154,331 +1,300	+0.8%	+$6.83K	0.01%	1322
2022 Q1	$1.35M	Buy	153,031 +100,861	+193%	+$1.11M	0.03%	742
2021 Q4	$837K	Buy	+52,170	New	+$982K	0.01%	1120
2021 Q3	–	Sell	-26,006	Closed	-$699K	–	2665
2021 Q2	$699K	Buy	26,006 +18,242	+235%	+$534K	0.01%	1020
2021 Q1	$247K	Sell	7,764 -128,321	-94%	-$3.12M	0.01%	1366
2020 Q4	$3.11M	Buy	+136,085	New	+$3.13M	0.09%	267
2020 Q3	–	Sell	-9,207	Closed	-$257K	–	1450
2020 Q2	$257K	Buy	+9,207	New	+$160K	0.01%	930
2020 Q1	–	Sell	-29,776	Closed	-$324K	–	1213
2019 Q4	$324K	Buy	+29,776	New	+$295K	0.01%	850
2019 Q1	–	Sell	-22,199	Closed	-$282K	–	1208
2018 Q4	$282K	Sell	22,199 -3	-0%	-$50	0.01%	780
2018 Q3	$476K	Sell	22,202 -306	-1%	-$6.52K	0.01%	701
2018 Q2	$465K	Sell	22,508 -16,554	-42%	-$373K	0.02%	692
2018 Q1	$983K	Buy	39,062 +24,596	+170%	+$597K	0.03%	331
2017 Q4	$275K	Sell	14,466 -5,563	-28%	-$104K	0.01%	847
2017 Q3	$370K	Buy	+20,029	New	+$347K	0.01%	746
2017 Q2	–	Sell	-13,759	Closed	-$256K	–	1237
2017 Q1	$256K	Sell	13,759 -1,200	-8%	-$23.1K	0.01%	1095
2016 Q4	$306K	Sell	14,959 -583	-4%	-$14.7K	0.01%	1015
2016 Q3	$465K	Buy	15,542 +2,684	+21%	+$79.8K	0.01%	772
2016 Q2	$347K	Buy	+12,858	New	+$290K	0.01%	1074
2015 Q2	–	Sell	-14,089	Closed	-$442K	–	1602
2015 Q1	$442K	Buy	14,089 +4,135	+42%	+$140K	0.01%	799
2014 Q4	$349K	Buy	+9,954	New	+$248K	0.01%	958

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Paul Tudor Jones's MGNX Position: Q2 2026 in Review

Paul Tudor Jones reduced its MacroGenics (MGNX) stake by 0.49% in Q2 2026, selling an estimated $303 and leaving 16,349 shares worth $75.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3421.

Paul Tudor Jones first reported a position in MGNX in Q4 2014 and has held it in 33 quarters since. The position peaked at $3.11M in Q4 2020. 121 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Paul Tudor Jones held 16,349 shares of MacroGenics worth $75.5K as of Q2 2026.
Paul Tudor Jones sold 80 MacroGenics shares in Q2 2026, an estimated $303.
MacroGenics made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #3421 holding.
Paul Tudor Jones first reported a position in MacroGenics in Q4 2014 and has held it in 33 quarters since.
Paul Tudor Jones's MacroGenics position peaked at $3.11M in Q4 2020.
121 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.